BCL10 anticorps (N-Term)
Aperçu rapide pour BCL10 anticorps (N-Term) (ABIN1732247)
Antigène
Voir toutes BCL10 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 5-19, N-Term
-
Specificité
- Reacts with human Bcl-10.
-
Purification
- Purified
-
Immunogène
- Synthetic peptide corresponding to aa 5-19 (N-terminus ) of human Bcl-10
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
IHC-P (10 μg/mL) WB(1 μg/mL) ICC(1 μg/mL) -
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS, pH 7.4
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Dilute in PBS or medium that is identical to that used in the assay system.
-
Stock
- -20 °C
-
Stockage commentaire
- Stable for at least one year at -20°C. Avoid multiple freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
-
Autre désignation
- Bcl-10
-
Sujet
-
Overexpression of Bcl10 induces JNK, p38, and NF- B activation. Bcl10 interacts with caspase- 9, enhances pro-caspase-9 processing, and induces apoptosis through caspase-9 activation. Bcl10 exhibits a variety of mutations in MALT lymphoma and in B and T cell lymphomas indicating that it may be commonly involved in the pathogenesis of human tumors. Bcl10 is expressed in many human and murine tissues and cell lines.
B-cell lymphoma/leukemia 10 B-cell CLL/lymphoma 10, Bcl-10 CARD-containing molecule enhancing NF-kappa-B CARD-like apoptotic protein, hCLAP CED-3/ICH-1 prodomain homologous E10-like regulator, CIPER Cellular homolog of vCARMEN, cCARMEN Cellular-E10, c-E10 Mammalian CARD-containing adapter molecule E10, mE10 Gene name: BCL10, CARMEN, CIPER, CLAP, IMD37 -
ID gène
- 8915
-
UniProt
- O95999
-
Pathways
- TCR Signaling, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteins
Antigène
-